Quantcast

Latest Immunohistochemistry Stories

2008-09-16 09:00:53

Invitrogen, a provider of essential life science technologies for research, production and diagnostics, has signed an exclusive US distribution agreement with Biocare Medical, a provider of immunohistochemistry reagents, multiplex stains, and automated platforms for the anatomic pathology market, for the new Spot-Light Her2 CISH kit. The Spot-Light Her2 CISH kit has received FDA premarket approval in July 2008, as an aid in the assessment of breast cancer patients for whom trastuzumab...

2008-09-15 18:00:37

Invitrogen Corporation, (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, has signed an exclusive U.S. distribution agreement with Biocare Medical LLC, a leading provider of immunohistochemistry reagents, multiplex stains, and automated platforms for the anatomic pathology market, for the new SPOT-Light(R) HER2 CISH Kit. The kit received U.S. Food and Drug Administration premarket approval in July, (click here for release), as an aid in...

2008-09-03 09:00:07

GAITHERSBURG, Md., Sept. 3 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. today announced the issuance of U.S. Patent Number 7,413,737 covering antibodies against human aspartyl (asparaginyl) beta-hydroxylase (HAAH), a proprietary human cancer biomarker and therapeutic target. These antibodies were developed in collaboration with the Massachusetts Institute of Technology (MIT) and Panacea has exclusive, worldwide rights to this patent for development of human cancer diagnostics and...

2008-08-20 09:01:30

Sigma-Aldrich has announced the addition of over 2,000 antibodies to its line of Prestige antibodies. These antibodies are developed by the Human Proteome Resource and are commercially available through an exclusive partnership with Sigma-Aldrich and Atlas Antibodies. The new antibodies were announced as the latest additions to the Human Protein Atlas portal. Initially consisting of 1,800 antibodies, the portfolio has grown to over 3,800 antibodies directed against 3,600 genes. The goal...

2008-08-19 18:00:43

ST. LOUIS, Aug. 19 /PRNewswire-FirstCall/ -- Sigma-Aldrich today announced the addition of over 2,000 antibodies to its line of Prestige Antibodies(TM). These antibodies are developed by the Human Proteome Resource and are commercially available through an exclusive partnership with Sigma-Aldrich and Atlas Antibodies. As part of a keynote HUPO 2008 Conference lecture given by Mathias Uhlen, Professor of Microbiology, Royal Institute of Technology (KTH) in Stockholm, Sweden, the new...

2008-07-31 09:00:28

SUNNYVALE, Calif., July 31 /PRNewswire/ -- Pathwork Diagnostics, Inc., a molecular diagnostics company focused on oncology, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Pathwork(R) Tissue of Origin Test for use in determining the origin of uncertain tumors. The test analyzes a tumor's gene expression pattern to help pinpoint the source of hard-to-identify tumors and is the first test of its kind to receive FDA clearance. Up to an estimated 200,000 newly...

2008-07-02 06:00:47

By Jensen, Kristin Theory and Practice of Histological Techniques, 6th Edition John D. Bancroft and Marilyn Gamble, editors Churchill Livingstone Elsevier Philadelphia, PA. Copyright (c) 2008 725 pages, $219.00, Hardcover This comprehensive text on histological methods is a well- organized, concise yet thorough reference designed for students of histology but suitable for a wide range of technicians and scientists in clinical and experimental settings. The authors focus on preserving...

2008-06-25 03:01:46

By Fisher, Ronald E Siegel, Barry A; Edell, Steven L; Oyesiku, Nelson M; Morgenstern, David E; Messmann, Richard A; Amato, Robert J ^sup 99m^Tc-EC20 is a folate receptor (FR)-targeted imaging agent consisting of the vitamin folate conjugated to ^sup 99m^Tc. FR is expressed on a variety of epithelial cancers, with advanced cancers often expressing FR at significantly higher levels than earlier stages of the disease. The goals of this pilot study were to determine the percentages of various...

2008-03-19 09:00:09

Targeted Molecular Diagnostics, LLC (TMD) announces the availability of the PhosphoGuard(TM) kit for preservation of phosphoproteins during tissue fixation and processing. When used as an additive to conventional fixatives, PhosphoGuard(TM) can prevent degradation of phosphorylated or "activated" proteins in patient tissue or xenograft specimens. Phosphorylated proteins are useful markers that may be essential in predicting patient response or resistance to targeted cancer therapies....

2008-02-13 03:00:14

By Deavers, Michael T Although most diagnoses in gynecologic pathology are established through the examination of routine hematoxylin eosin-stained slides, immunohistochemical studies can be of assistance in some cases. The following case studies are used to illustrate the value of some relatively new markers in the diagnosis of gynecologic neoplasms and to highlight potential diagnostic pitfalls. (Arch Pathol Lab Med. 2008;132:175-180) CASE 1 Case History The patient is a 59-year-old...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related